SEC Recommends Bharat Biotech to Conduct Late-stage Trials, Submit Booster Protocol

This is a needle-free, non-invasive and easy to administer vaccine, which is expected to be suitable for both children and adults.

from Top India News- News18.com https://ift.tt/3mWCGoa
This is a needle-free, non-invasive and easy to administer vaccine, which is expected to be suitable for both children and adults.